Ledger.Open graph →
SEC Form D · filed March 12, 2015

NeuroGenetic Pharmaceuticals, Inc

Offering
$60K
Sold
$50K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DEL MAR, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

William T. Comer · Del Mar, CAExec · DirectorBarry T. Quart · Del Mar, CADirectorTom T. Reed · Del Mar, CADirectorMichael P. Knapp · NEW YORK, NYDirectorRichard A. Baker · NEW YORK, NYDirectorMichael J. Fox · NEW YORK, NYExec · DirectorVikram Deswal · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗